A consensus viewpoint on the role of direct factor Xa inhibitors in the management of cancer-associated venous thromboembolism in the UK

Alexander T. Cohena Guy’s and St Thomas’ NHS Foundation Trust, King’s College London, London, UKCorrespondence[email protected]

Gary Bensonb Northern Ireland Haemophilia Comprehensive Care Centre and Thrombosis Unit, Belfast, UK

Charlotte A. Bradburyc Faculty of Health Sciences, University of Bristol, Bristol, UK

Satarupa Choudhurid Pennine Acute Hospitals NHS Trust, Manchester, UK

Nathan Hutchinson Jonese Royal United Hospitals, Bath, UK

Anthony Maraveyasf Queen’s Centre for Oncology and Haematology, Hull, UK

Balaji Venugopalg The Beatson West of Scotland Cancer Centre, Glasgow, UK;h Institute of Cancer Sciences, University of Glasgow, Glasgow, UK

Annie M. Youngi Warwick Clinical Trials Unit, University of Warwick, Coventry, UK

Chris Chapmanj Bristol Myers Squibb, Uxbridge, UK

Shauna McIntyrej Bristol Myers Squibb, Uxbridge, UK

Danny Burneyj Bristol Myers Squibb, Uxbridge, UK

Kevin G. Pollockj Bristol Myers Squibb, Uxbridge, UK

Angharad R. Morgank Health Economics and Outcomes Research Ltd., Cardiff, UK

Peter D. Gabbk Health Economics and Outcomes Research Ltd., Cardiff, UK

Raza Alikhanl Haemophilia and Thrombosis Centre, University Hospital of Wales, Cardiff, UK;m Cardiff University School of Medicine, Cardiff, UK

Your download is now in progress and you may close this window